Haemonetics FY2025 EPS Forecast Decreased by Zacks Research
Haemonetics Co. (NYSE:HAE – Free Report) – Investment analysts at Zacks Research reduced their FY2025 earnings estimates for shares of Haemonetics in a research report issued to clients and investors on Monday, February 17th. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings of $4.56 per share for the […]
